Fuji Pharma Co., Ltd. (TYO:4554)
Japan · Delayed Price · Currency is JPY 1,891.00
-9.00 (-0.47%)
Jan 21, 2026, 3:30 PM JST
Fuji Pharma Revenue
In the fiscal year ending September 30, 2025, Fuji Pharma had annual revenue of 51.68B JPY with 12.01% growth. Fuji Pharma had revenue of 14.72B in the quarter ending September 30, 2025, with 13.40% growth.
Revenue
51.68B
Revenue Growth
+12.01%
P/S Ratio
0.90
Revenue / Employee
29.36M
Employees
1,760
Market Cap
46.46B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2025 | 51.68B | 5.54B | 12.01% |
| Sep 30, 2024 | 46.14B | 5.25B | 12.84% |
| Sep 30, 2023 | 40.89B | 5.46B | 15.42% |
| Sep 30, 2022 | 35.43B | 1.44B | 4.22% |
| Sep 30, 2021 | 33.99B | 197.00M | 0.58% |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Takeda Pharmaceutical Company | 4.42T |
| Otsuka Holdings | 2.42T |
| Astellas Pharma | 2.01T |
| Daiichi Sankyo Company | 1.98T |
| Chugai Pharmaceutical | 1.21T |
| Terumo | 1.06T |
| Olympus | 977.65B |
| HOYA Corporation | 892.50B |
Fuji Pharma News
- 4 months ago - Alvotech Receives Marketing Approval In Japan For Three New Biosimilars - Nasdaq
- 7 months ago - Alvotech's Lenders Lower Interest on Senior Secured Term Loan Facility - Benzinga
- 11 months ago - Olic anticipates buoyant demand for contraceptives - Bangkok Post